Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

German Hospital Treats US Ebola Patient Infected in Congo

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Alcohol Emergencies: When Is It More Than Intoxication?

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

Risk Stratification May ID Paraneoplastic Dermatomyositis

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

Elevated Interferon Alfa May Reveal Sjögren Disease Subtype

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

News All Time

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

Pernicious Anemia: How a Fatal Disease Became Treatable

Once nearly always fatal, pernicious anemia became treatable through a series of discoveries linking the stomach, liver, and ultimately vitamin B12.

Uveitis Patterns Vary in Relation to Spondyloarthritis Type

Patients with peripheral forms of spondyloarthritis show a higher prevalence of different uveitis patterns than those with axial forms.

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

The Essential Clinical Research You’re Probably Not Reading

Qualitative research has long been viewed as less rigorous and less important — but that’s changing. Here’s where to find the highest-quality studies and how to use them to help your patients.

Can CRISPR Make CAR T Safer and More Scalable?

Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease.

Pain Persists Despite Low Inflammation in Many With Early RA

Patients newly diagnosed with rheumatoid arthritis often experience unacceptable pain at 2 years despite having low levels of inflammation, a study finds.

AI Is Making Uneven Inroads in Pulmonary Medicine

AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and prediction, but significant gaps between development and deployment.

Abrocitinib Boosts Skin Clearance and Itch Relief in AD

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to dupilumab, a post hoc study shows.
HTTP error: 503

When Patient Self-Scheduling Collides With Acute Care

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?
HTTP error: 503HTTP error: 503

Which Medications Increase Heat-Related Risk in Patients?

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and heatstroke.
HTTP error: 503

US FDA Approves Vera's Kidney Disease Drug

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug to treat ⁠patients with a potentially life-threatening kidney...

Recommended News For You

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke

Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

Recommended Articles For You

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment 

AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Waiting for a Sharp Increase in Prostate Cancer Cases.

2.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

3.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

4.

Which Risk Model Better Identifies High-Risk Smoldering MM?

5.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

1.

The Danger of Methemoglobinemia and How to Prevent It 

2.

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment

3.

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment

4.

Everything You Need to Know About Normal Potassium Levels 

5.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot